This Guidelines in Practice animation has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines in Practice. Norgine Pharmaceuticals Limited suggested the topic for the animation, worked with MGP Ltd to choose and commission the presenter, and approved all materials related to the animation. The views and opinions expressed in the animation are not necessarily those of Norgine Pharmaceuticals Limited, or Guidelines in Practice, its publisher, advisers, or advertisers.
There has been a significant increase in the prevalence of chronic liver disease in the UK, and as a result, hospital admissions and deaths due to liver disease have also increased.1
A ‘care bundle’ has been developed for patients admitted with decompensated cirrhosis (of all aetiologies) to provide guidance to healthcare professionals on the effective evidence-based treatments that should be delivered within the first 24 hours.1
Watch this short animation to learn about:
- the appropriate investigations that should be undertaken when a patient presents with decompensated cirrhosis
- the initial management of alcohol withdrawal, infection, acute kidney injury, gastrointestinal bleeding and encephalopathy
- postdischarge management.
Click here to read ’Implementation of a ‘care bundle’ improves the management of patients admitted to hospital with decompensated cirrhosis’ By clicking on this link you will leave the Guidelines website. MGP Ltd does not accept responsibility for the content of third party websites.
- McPherson S, Dyson J, Austin A, Hudson M. Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h. Frontline Gastroenterology 2016; 7 (1): 16–23.
Date of preparation: January 2018